Milos Fulton Peluffo

Fon Technology SL develops shared wireless internet access network based on Wi-Fi technology. The firm's solutions enable service providers to configure, deliver and operate their own WiFi services. The company was founded by Martin Varsavsky Waisman-Diamond in 2006 and is headquartered in Madrid, Spain.

Integrated Plasmonics Corp. operates as a nanotechnology company. The company was founded on February 4, 2011 and is headquartered in San Francisco, CA.

Part of Orange SA, FT España ISP is a company based in Alcobendas, Spain. FT España ISP operates as an Internet service provider. The Spanish company was founded by Martín Varsavsky Waisman-Diamond. FT España ISP was acquired by Orange SA from Deutsche Telekom AG on August 01, 2007 for $432.72 million.

Insight Venture Management LLC (Insight Venture Partners) is a private equity and venture capital firm, a subsidiary of Insight Holdings Group LLC founded in 1995 by Jeffrey L. Horing and Jerry Fred Murdock. The firm is headquartered in New York.

Charles River Ventures, Inc. is a venture capital firm founded in 1970. The firm is headquartered in Cambridge, Massachusetts.

Orange Espagne SA is a telecommunications company. It is engaged in providing fixed telephone, mobile phone and internet services, television broadcasting, and audiovisual and interactive content. The company was founded in 1988 and is headquartered in Pozuelo de Alarcón, Spain.

Eolia Renovables de Inversiones SCR SA invests in mid-sized renewable energy companies located in Europe, primarily in Spain. The fund targets companies operating in the alternative power generator industry including specific wind and solar projects.

Jazzya Investments SL is a private company based in Madrid, Spain. The Spanish company operates a blog that focuses on entrepreneurship.

The Varsavsky Foundation is a grant making organization which operates an online political blog. Its projects include www.educ.ar, www.educarchile.cl, safe-democracy.org, and Atocha workshop. The company was founded by Martín Varsavsky Waisman-Diamond in May 2000 and is headquartered in Alcobendas, Spain.

FON Wireless Ltd. Operates as a telecommunications company. The firm engages in the provision of internet access services and voice image and data transmission. The company was founded by Martín Varsavsky Waisman on November 10, 2005 and is headquartered in London, the United Kingdom.

Prelude Fertility, Inc. operates as a fertility company. Its network of fertility clinics and egg donation centers offers egg freezing, egg storage, genetic testing, IVF and egg donation services. The company was founded by Martin Varsavsky Waisman in October 2016 and is headquartered in Atlanta, GA.

Overture Life, Inc. operates as a biotechnology firm. The company was founded by Martin Varsavsky, Santiago Munné and José Horcajadas and is headquartered in New York, NY.

VAS Ventures is a venture capital firm founded by Martín Varsavsky Waisman in 2017. The firm is headquartered in Spain.

Deciduous Therapeutics, Inc. engages in the biotechnology business. It develops novel therapies to activate the endogenous immune system to treat age related diseases. The company is headquartered in San Francisco, CA.

Dyno Therapeutics, Inc. engages in the development of therapeutics technologies. It develops technologies for safe, efficient and targeted in vivo delivery of new gene therapies and genome editing therapies. The company was founded by Kelsic Eric David and is headquartered in Watertown, MA.

Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA.

Goggo Network GmbH develops the legal and engineering framework of European autonomous mobility networks. The company was founded by Martin Varsavsky and Yasmine Fage in September 2018 and is headquartered in Berlin, Germany.

Viatel Ireland Ltd. provides telecommunications, cyber security, and software services. Its solutions include secure connectivity, cyber security, and colocation. The company was founded by Martín Varsavsky Waisman and is headquartered in Dublin, Ireland.

Switch Therapeutics, Inc. is an American biotechnology company that aims to treat a range of diseases affecting the central nervous system and systemic indications with significant unmet need. Switch is based in , and was founded by Dee Datta, who has been the CEO since incorporation. The company is pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science. The company's novel gene knockdown approach, the Conditionally Activated siRNA (CASI) platform, is based on technology developed by renowned researchers in the field of RNA and drug development from Caltech, Harvard Medical School, and City of Hope.

Barter Energia SL is a Spanish company that offers a new way of generating and consuming solar energy in urban areas without any investment. The company is based in Madrid, Spain and has subsidiaries in Spain. The company provides a solar community for the future. The company was founded in 2020 by Martín Varsavsky Waisman-Diamond, Maria Isabel Reija Ruiz, and Miguel Santiago Salis Canosa. Maria Isabel Reija Ruiz has been the CEO since 2020.

ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018.

ArrePath, Inc. is an anti-infective drug discovery company that focuses on addressing the health challenge of drug-resistant infections. The platform's proof-of-concept has been demonstrated in studies published in Cell by ArrePath's scientific founder, Zemer Gitai, Ph.D., Edwin Grant Conklin Professor of Biology at Princeton University. The company is based in Princeton, NJ, and is funded by the Boehringer Ingelheim Venture Fund, Insight Partners, Innospark Ventures, Viva BioInnovator, Arimed Capital, PTX Capital, and Nor'easter Ventures. The company utilizes a proprietary machine learning-based platform to efficiently identify anti-infective agents with new mechanisms of action at the outset of the discovery process. This is achieved through a deep understanding and analysis of pathogen behavior. The CEO of the company is Lloyd J. Payne.

DEM BioPharma, Inc. is an American company that pioneers the next generation of immunotherapeutics to eliminate tumors by targeting 'don't eat me' and 'eat me' signals on cancer cells, macrophages, and other myeloid effector cells. The company is based in Cambridge, MA. The proprietary CHOMP™ platform utilizes CRISPR-based functional genomic screens to discover and validate new signals that could enhance cancer cell elimination through increased phagocytosis. The company was founded by Longwood Fund and builds on groundbreaking functional genomics research and discoveries in macrophage biology from its scientific co-founders. Nenad Grmusa has been the CEO of the company since 2022.

Part of Barter Energia SL, Blaudrive SL provides charging services for electric vehicles. The company is based in Barcelona, Spain. Blaudrive was acquired by Barter Energia SL on October 25, 2022.

Capacity Bio, Inc. is a biotech company based in an undisclosed location. The American company is focused on developing a first-in-class mitophagy therapeutic platform and an advanced analytical toolkit to characterize mitochondria. The company was founded by Amy Wang, Stan Louie, and Kathy Rodgers, and the CEO is Kenneth Nicholas Horne.

Vecprobio Inc. develops manufacturing technologies and tools for gene therapy. The company is based in San Diego, CA. The company was founded in 2022. Daniel Gibbs has been the CEO of the company since 2022.

Superluminal Medicines Inc is a generative biological and chemical company. The company is based in Boston, MA. The CEO of the company is Cony D'Cruz.